Rehabilitation Exo-Walker Global Market Report 2025

The rehabilitation exo-walker market size has grown rapidly in recent years. It will grow from $1.51 billion in 2024 to $1.76 billion in 2025 at a compound annual growth rate (CAGR) of 16.5%. The growth during the historic period is attributed to the rising prevalence of mobility disorders, increasing government healthcare initiatives, growing adoption of assistive devices in hospitals, higher demand for physical therapy solutions, and an expanding geriatric population.

The rehabilitation exo-walker market size is expected to see rapid growth in the next few years. It will grow to $3.21 billion in 2029 at a compound annual growth rate (CAGR) of 16.1%. The growth during the forecast period is attributed to rising demand in emerging economies, increasing adoption of home-based rehabilitation, expanding insurance coverage for rehabilitation devices, growing clinical trials and validation studies, and a stronger focus on patient-centric care. Key trends in the forecast period include the development of robotics-based rehabilitation protocols, integration of wearable biosensors, innovations in energy-efficient actuation systems, integration with mobile applications for remote guidance and feedback, and the creation of modular exo-walker designs.

The rising incidence of neurological disorders is expected to drive the growth of the rehabilitation exo-walker market. Neurological disorders are medical conditions affecting the brain, spinal cord, or nerves, leading to impairments in movement, cognition, sensation, or overall nervous system function. The increase in these disorders is linked to lifestyle factors such as poor diet, physical inactivity, chronic stress, smoking, and excessive alcohol consumption, which collectively raise the risk of conditions such as stroke, dementia, and neurodegenerative diseases. Rehabilitation exo-walkers support recovery in patients with neurological disorders by providing guided, repetitive, and precise movement training that improves motor function, balance, and gait. For example, in March 2023, the Alzheimer's Association reported that 6.7 million Americans aged 65 and older were living with Alzheimer's dementia, with projections indicating this could rise to 13.8 million by 2060. This rising prevalence is contributing to the growth of the rehabilitation exo-walker market.

Key companies in the rehabilitation exo-walker market are developing innovative solutions, such as advanced exoskeletal neuro devices, to enhance mobility and recovery for patients with neurological disorders. Exoskeletal neuro devices are wearable robotic systems designed to support and enhance movement by assisting the nervous system and muscles, helping patients regain mobility and strength after neurological injuries or disorders. For instance, in April 2024, JK Physio and Rehab Clinics, an India-based proprietorship firm, launched an advanced exoskeletal neuro device aimed at faster recovery for fully and partially paralyzed patients. The device integrates neurostimulation and robotic support to enhance spinal and muscular function, offering significant improvements over conventional rehabilitation methods. It personalizes therapy according to each patient’s level of paralysis, enabling gradual restoration of mobility and strength. Early clinical observations indicate notable improvements in recovery speed, patient engagement, and overall quality of life.

In April 2025, ExoAtlet Asia Co. Ltd., a Luxembourg-based international healthtech company specializing in wearable exoskeletons for rehabilitation, partnered with Wecare Medlease to offer flexible leasing solutions for clinics and patients. The partnership aims to make ExoAtlet’s advanced medical exoskeletons widely accessible through an affordable leasing and rental model. Wecare Medical Technology Co. Ltd., based in China, manufactures medical devices including surgical instruments, pathology equipment, and internal fixation devices for bone fractures.

Major players in the rehabilitation exo-walker market are Toyota Motor Corporation, Fourier Intelligence, Wandercraft S.A, CYBERDYNE INC., Ekso Bionics Holdings Inc., ReWalk Robotics Ltd., ExoAtlet Asia Co. Ltd., HD Hyundai Robotics Co. Ltd., Marsi Bionics, Trexo Robotics Holdings Inc., Bionik Laboratories Corp., ABLE Human Motion S.L., Angel Robotics Co. Ltd., NextStep Robotics Inc., Laevo B.V., FREE Bionics Taiwan Inc., Biomotum Inc., Technaid S.L., Gogoa Mobility Robots, and Syrebo.

North America was the largest region in the rehabilitation exo-walker market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in rehabilitation exo-walker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The rehabilitation exo-walker market research report is one of a series of new reports that provides rehabilitation exo-walker market statistics, including rehabilitation exo-walker industry global market size, regional shares, competitors with a rehabilitation exo-walker market share, detailed rehabilitation exo-walker market segments, market trends and opportunities, and any further data you may need to thrive in the rehabilitation exo-walker industry. This rehabilitation exo-walker market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A rehabilitation exo-walker is a wearable robotic device designed to assist individuals with lower-limb impairments in walking and regaining mobility. It provides support, stability, and guided movement during physical therapy to enhance rehabilitation outcomes.

The primary types of rehabilitation exo-walkers include lower limb exo-walkers, upper limb exo-walkers, and full body exo-walkers. A lower limb exo-walker is a wearable robotic device that supports, assists, or enhances the movement of the legs, hips, knees, and/or ankles for individuals with mobility impairments, typically used in rehabilitation or mobility assistance. Based on mobility type, these devices can be powered or passive. They are applied in areas such as stroke rehabilitation, spinal cord injury recovery, orthopedic rehabilitation, neurological rehabilitation, and more, serving end users including hospitals, rehabilitation centers, homecare settings, and others.

The countries covered in the rehabilitation exo-walker market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The rehabilitation exo-walker market consists of sales of pneumatic exo-walkers, soft exosuits, motorized ankle-foot exoskeletons, assistive walking exoskeletons, and balance training exo-walkers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.